Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner
Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It...
Gespeichert in:
| Veröffentlicht in: | BMC urology Jg. 23; H. 1; S. 69 - 6 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
28.04.2023
BioMed Central Ltd Springer Nature B.V BMC |
| Schlagworte: | |
| ISSN: | 1471-2490, 1471-2490 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Introduction
Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting.
Methods
This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant.
Results
Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%.
Conclusion
Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. |
|---|---|
| AbstractList | Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting. This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant. Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%. Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting. This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant. Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%. Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. IntroductionMultiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting.MethodsThis was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant.ResultsOut of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%.ConclusionOur results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting. Methods This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant. Results Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%. Conclusion Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. Keywords: Clinically significant prostate cancer, Multiparametric magnetic resonance imaging, PI-RADS score, Trans perineal prostate biopsy Abstract Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting. Methods This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant. Results Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%. Conclusion Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting. Methods This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant. Results Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%. Conclusion Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting.INTRODUCTIONMultiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate cancer (PCa). It effectively identifies patients who require prostate biopsies due to the risk of clinically significant PCa. It helps patients with clinically insignificant PCa avoid the invasive biopsies and possible accompanying complications. Large clinical trials have investigated the accuracy of mpMRI in detecting PCa. We performed a local review to examine the reliability of omitting tissue sampling in men with a negative (PIRADS 2 (P2) or less) mpMRI in the primary diagnostic setting.This was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant.METHODSThis was a retrospective study of patients with clinical suspicion of PCa within a 2-year period. Patients had a mpMRI prior to having trans-perineal prostate gland biopsies. Clinically significant disease was defined as Gleason 7 and above. The descriptive data was analysed using contingency table methods. A p-value less than 0.05 was statistically significant.Out of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%.RESULTSOut of 700 patients 90 had an mpMRI score of PIRADS 2. Seventy-seven (85.5%) of these patients had a negative biopsy, 9(10%) showed Gleason 6, 4 patients showed Gleason 7 or above. 78 patients with PIRADS 2 had a PSA density of < 0.15, none of which had a clinically significant biopsy result. The negative predictive value of mpMRI from this study is 95%.Our results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies.CONCLUSIONOur results are in line with negative predictive values demonstrated in the current literature. This local study, likely applicable to other district general hospitals, shows that mpMRI is a safe and reliable initial investigation to aid decisions on which patients require biopsies. |
| ArticleNumber | 69 |
| Audience | Academic |
| Author | Sharqawi, Abdallah O’reilly, Alison Shugaba, Abdul Drye, Naomi El-Sakka, A I Kadry, Ahmed M. |
| Author_xml | – sequence: 1 givenname: Abdallah surname: Sharqawi fullname: Sharqawi, Abdallah email: abdallah_elmagd@yahoo.com organization: Urology Dept, Royal Bolton Hospital, Urology Dept, Faculty of Medicine, Suez Canal University – sequence: 2 givenname: Naomi surname: Drye fullname: Drye, Naomi organization: Urology Dept, Royal Bolton Hospital – sequence: 3 givenname: Abdul surname: Shugaba fullname: Shugaba, Abdul organization: Urology Dept, Royal Bolton Hospital – sequence: 4 givenname: Alison surname: O’reilly fullname: O’reilly, Alison organization: Urology Dept, Royal Bolton Hospital – sequence: 5 givenname: Ahmed M. surname: Kadry fullname: Kadry, Ahmed M. organization: Urology Dept, Faculty of Medicine, Suez Canal University – sequence: 6 givenname: A I surname: El-Sakka fullname: El-Sakka, A I organization: Urology Dept, Faculty of Medicine, Suez Canal University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37118694$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ksuOFCEYhStmjHPRF3BhSNy4qRYooGBlJhMvk0xiYnRNKC4lHRpaqJrY7-EDS3WP0zPGGBbF5fsPdX7OeXMSU7RN8xLBFUKcvS0Ic0FaiLsWIkxQy540Z4j0qMVEwJMH89PmvJQ1hKjnlD1rTrt-ERDkrPn1xQavBh_8tAPJgW1OZVKTBX6jRh9HkO025WmZqWiAUZMCZVcmuwG3NhefIsArBFzKwP7UYTYLqYOPXqsQdqD4MXpXF3E6ateVthnMZS8L0IqCyZZQletJtPl589SpUOyLu-9F8-3D-69Xn9qbzx-vry5vWk2pmFrdaYGYY3igw8C5ENQMClqGNYWDY8QMzvGOUYEphNDoXguOKTbOUoLc0HUXzfVB1yS1lttcPeedTMrL_UbKo1TVuw5W9h3lwiAIGekJo5qTHgvMemsZUsaQqvXuoLWdh4012sYpq_BI9PFJ9N_lmG4lgohwIpa_eXOnkNOP2ZZJbnzRNgQVbZqLxBz2AnGKlste_4Wu05xj7VWlUG2OoJgeqVFVBz66VC_Wi6i87KuNbmlLpVb_oOowduN1TZzzdf9RwauHTu8t_glVBfAB0PXBS7buHkFQLow8JFfW5Mp9ciWrRd2hqFQ4jjYfLf2n6jegze_b |
| Cites_doi | 10.1016/j.eururo.2011.12.058 10.1016/j.juro.2011.03.015 10.1016/j.eururo.2020.03.048 10.1148/radiol.09090475 10.1016/S0140-6736(16)32401-1 10.1016/S0033-8389(05)70150-0 10.1148/radiographics.15.4.7569131 10.1111/bju.13556 10.1016/S1076-6332(01)90095-9 10.1007/s00330-011-2377-y 10.1148/radiol.2015142818 10.1111/bju.14853 10.1007/s00330-014-3150-9 10.2214/AJR.13.11046 10.1056/NEJMoa1801993 10.1016/j.heliyon.2021.e08325 10.1148/radiol.13130801 10.1111/bju.14809 10.1007/s00330-018-5707-9 10.1016/j.eururo.2015.01.013 10.1590/s1677-5538.ibju.2015.0690 10.1016/j.eururo.2019.02.033 |
| ContentType | Journal Article |
| Copyright | Crown 2023 2023. Crown. COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: Crown 2023 – notice: 2023. Crown. – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12894-023-01241-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2490 |
| EndPage | 6 |
| ExternalDocumentID | oai_doaj_org_article_73589d100647465c84729267ee61add4 PMC10148493 A747435000 37118694 10_1186_s12894_023_01241_6 |
| Genre | Journal Article |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c559t-c3c916f62b5bb88995dba0e62c50bf64dbff8365925000dc7c98252dfe541fb33 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000976078400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2490 |
| IngestDate | Fri Oct 03 12:32:09 EDT 2025 Tue Nov 04 02:06:50 EST 2025 Sun Nov 09 09:12:46 EST 2025 Sat Oct 11 05:43:55 EDT 2025 Tue Nov 11 10:20:16 EST 2025 Tue Nov 04 17:57:00 EST 2025 Thu Jan 02 22:52:50 EST 2025 Sat Nov 29 02:21:32 EST 2025 Sat Sep 06 07:22:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Clinically significant prostate cancer Multiparametric magnetic resonance imaging Trans perineal prostate biopsy PI-RADS score |
| Language | English |
| License | 2023. Crown. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c559t-c3c916f62b5bb88995dba0e62c50bf64dbff8365925000dc7c98252dfe541fb33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/s12894-023-01241-6 |
| PMID | 37118694 |
| PQID | 2815599525 |
| PQPubID | 42551 |
| PageCount | 6 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_73589d100647465c84729267ee61add4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10148493 proquest_miscellaneous_2807918514 proquest_journals_2815599525 gale_infotracmisc_A747435000 gale_infotracacademiconefile_A747435000 pubmed_primary_37118694 crossref_primary_10_1186_s12894_023_01241_6 springer_journals_10_1186_s12894_023_01241_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-04-28 |
| PublicationDateYYYYMMDD | 2023-04-28 |
| PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-28 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC urology |
| PublicationTitleAbbrev | BMC Urol |
| PublicationTitleAlternate | BMC Urol |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | G Litjens (1241_CR21) 2019; 29 1241_CR30 SS Sonnad (1241_CR9) 2001; 8 RR Tourinho-Barbosa (1241_CR1) 2016; 42 AB Rosenkrantz (1241_CR13) 2020; 203 JJ Fütterer (1241_CR10) 2015; 68 N Schieda (1241_CR22) 2014; 24 FJH Drost (1241_CR16) 2019; 4 V Stefanova (1241_CR25) 2019; 201 NJ Sathianatthen (1241_CR17) 2020; 743 RD Harris (1241_CR8) 1995; 15 KK Yu (1241_CR2) 2000; 38 1241_CR19 1241_CR18 1241_CR15 B Turkbey (1241_CR7) 2010; 255 1241_CR12 M de Rooij (1241_CR14) 2014; 202 1241_CR11 1241_CR20 W Venderink (1241_CR29) 2019; 124 1241_CR3 HU Ahmed (1241_CR6) 2017; 389 1241_CR4 1241_CR28 1241_CR27 1241_CR26 V Kasivisvanathan (1241_CR5) 2018; 378 1241_CR24 1241_CR23 |
| References_xml | – ident: 1241_CR26 doi: 10.1016/j.eururo.2011.12.058 – ident: 1241_CR24 doi: 10.1016/j.juro.2011.03.015 – volume: 743 start-page: 402 year: 2020 ident: 1241_CR17 publication-title: Eur Urol Sept doi: 10.1016/j.eururo.2020.03.048 – volume: 255 start-page: 89 year: 2010 ident: 1241_CR7 publication-title: Radiology doi: 10.1148/radiol.09090475 – volume: 201 start-page: 6 year: 2019 ident: 1241_CR25 publication-title: Jun – volume: 389 start-page: 815 year: 2017 ident: 1241_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(16)32401-1 – volume: 38 start-page: 59 year: 2000 ident: 1241_CR2 publication-title: Radiol Clin North Am doi: 10.1016/S0033-8389(05)70150-0 – volume: 203 start-page: 749 issue: 4 year: 2020 ident: 1241_CR13 publication-title: J Urol – volume: 15 start-page: 813 year: 1995 ident: 1241_CR8 publication-title: Radiographics doi: 10.1148/radiographics.15.4.7569131 – ident: 1241_CR18 doi: 10.1111/bju.13556 – volume: 8 start-page: 149 year: 2001 ident: 1241_CR9 publication-title: Acad Radiol doi: 10.1016/S1076-6332(01)90095-9 – ident: 1241_CR11 doi: 10.1007/s00330-011-2377-y – ident: 1241_CR20 doi: 10.1148/radiol.2015142818 – ident: 1241_CR15 – volume: 124 start-page: 775e84 issue: 5 year: 2019 ident: 1241_CR29 publication-title: BJU Int doi: 10.1111/bju.14853 – volume: 24 start-page: 1349 year: 2014 ident: 1241_CR22 publication-title: Eur Radiol doi: 10.1007/s00330-014-3150-9 – volume: 202 start-page: 343 issue: 2 year: 2014 ident: 1241_CR14 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.13.11046 – volume: 378 start-page: 1767 year: 2018 ident: 1241_CR5 publication-title: N Engl J Med doi: 10.1056/NEJMoa1801993 – ident: 1241_CR4 doi: 10.1016/S0140-6736(16)32401-1 – ident: 1241_CR30 doi: 10.1016/j.heliyon.2021.e08325 – ident: 1241_CR27 – ident: 1241_CR12 doi: 10.1148/radiol.13130801 – ident: 1241_CR23 – ident: 1241_CR3 doi: 10.1111/bju.14809 – volume: 4 start-page: CD012663 year: 2019 ident: 1241_CR16 publication-title: Cochrane Database Syst Rev – ident: 1241_CR28 – volume: 29 start-page: 1600 issue: 4 year: 2019 ident: 1241_CR21 publication-title: Eur Radiol doi: 10.1007/s00330-018-5707-9 – volume: 68 start-page: 1045 year: 2015 ident: 1241_CR10 publication-title: Eur Urol doi: 10.1016/j.eururo.2015.01.013 – volume: 42 start-page: 1081 year: 2016 ident: 1241_CR1 publication-title: Int Braz J Urol doi: 10.1590/s1677-5538.ibju.2015.0690 – ident: 1241_CR19 doi: 10.1016/j.eururo.2019.02.033 |
| SSID | ssj0017856 |
| Score | 2.2955651 |
| Snippet | Introduction
Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection... Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection of Prostate... Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection... IntroductionMultiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the detection... Abstract Introduction Multiparametric magnetic resonance imaging (mpMRI) of the prostate gland is now the recommended initial investigation of choice for the... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 69 |
| SubjectTerms | Biopsy Clinical significance Clinical trials Clinically significant prostate cancer Family medical history Humans Image-Guided Biopsy - methods Internal Medicine Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Medical research Medicine Medicine & Public Health Medicine, Experimental Multiparametric Magnetic Resonance Imaging Patients Perineum PI-RADS score Prostate - pathology Prostate cancer Prostatic Neoplasms - pathology Reproducibility of Results Retrospective Studies Statistical analysis Trans perineal prostate biopsy Urology |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJtAQUZC4gBpY8d2nGNBVByg4gCoNyt-iZW22WofFf0f_cGdsZNtU4S4cFutvZbteXhmZ-YbQt5YsBGiEL4UUsZSWC9LraMso7SBdz7ILnVR-PmlOTrSx8ftt2utvjAnLMMD54vbb2qpW89SUaRQ0oE25S1XTQiKgWwmJNCqaUdnaogfNFqqsURGq_0VaGGEwOWYOwRvVqkmz1BC6_9TJ197lG4mTN6ImqbH6PA-uTdYkfQg7_4BuRX6h-TO1yFO_ohcYKZxRuA-p4tIT7G2A6xKOjtJXYloDhXgp673FNNEacZ0pmf5DzTK9xgFg5aG326-wQeOjkWU83OKWR-YYwRkuVrbIQMtKWbSw7KU7UkKduwcVoaRPiwfkx-Hn75__FwO_RdKB37GunS1A-MxKm6ltRocM-ltVwXFnaxsVMLbGHWNcVnsquBd41rwN7mPQQoWbV0_ITv9og_PCG1410bHQJvJSgjJtXJRuAC0ZK7tZFWQdyM5zGmG2TDJPdHKZOIZIJ5JxDOqIB-QYtuZCJGdvgDGMQPjmH8xTkHeIr0NCjIQ1XVDPQJsGCGxzAE4WmBLwskKsjuZCQLopsMjx5hBAawM1yxhuXFZkNfbYfwlJrX1YbHBOcC4YC8x2MvTzGDbI9UNnr2FET1hvcmZpyP97FeCB8fuy1q0dUHej1x6ta-_X-rz_3GpL8hdnqRMlFzvkp31chNektvubD1bLV8lGb0EDZ49eQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgi1AvvFsCBRkJiQOkmzi245xQQVQg0WoPgMrJSvyAlZZk2UdF_wc_mBkn2SVFcOK2Wnstz-bzzDgz8w0hTyvwETznNuZC-JhXVsRKeRF7UTlWWifK0EXh0_v89FSdnRWTrjx62aVV9joxKOqW7RnztkEJj21j8I35mKk0UGUx8XL-PcYeUhhr7RpqXCU7SLyVjMjO5N3J5PMmqpArIfvCGSXHS9DNSIzLMKMILFksB8YpcPj_qal_M1WX0ygvxVKDiTq--X-Fu0VudK4qPWqxdZtccfUdcv2kC8bfJT8xnbml-b6gjadzLCAB15VOv4XWR7SNR-CnsrYUc1FpSxxNz9u3dJQdphS8Zup-mNkarSjtKzVnFxRTSzCRCZ79dm2DKF1QTNeHZWl6KCg4yzNYGUZqt7hHPh6_-fD6bdw1eYgNCLmKTWbAQ_WSVaKqFNz-hK3KxElmRFJ5yW3lvcow-IutG6zJTQGXWma9Ezz1VZbtkVHd1O4-oTkrC29SUJki4VwwJY3nxnG45JqiFElEnvdPV89bLg8d7kBK6hYLGrCgAxa0jMgrBMBmJvJwhy-axRfdHWudZ0IVNg0lu1wKA7aeFUzmzskULAePyDOEj0ZtARgxZVf0ABtG3i19BLc5cFhBsogcDGbCKTfD4R45utMyS70FSkSebIbxl5g5V7tmjXOSvACnLIW97Ld43YiU5Sh7ASNqgOSBzMORevo1cJBji2fFiywiL3rQb_f19z_1wb_FeEh2WTiOPGbqgIxWi7V7RK6Z89V0uXjcHedf02ZaNg priority: 102 providerName: ProQuest |
| Title | Reliability of prostate imaging reporting and data system version 2.1 for excluding clinically significant prostate cancer using a 1.5 tesla scanner |
| URI | https://link.springer.com/article/10.1186/s12894-023-01241-6 https://www.ncbi.nlm.nih.gov/pubmed/37118694 https://www.proquest.com/docview/2815599525 https://www.proquest.com/docview/2807918514 https://pubmed.ncbi.nlm.nih.gov/PMC10148493 https://doaj.org/article/73589d100647465c84729267ee61add4 |
| Volume | 23 |
| WOSCitedRecordID | wos000976078400005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1471-2490 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017856 issn: 1471-2490 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bbtMw9IhtCPHC_RIYlZGQeICMxrEd53FDm0BiVcVlKk9W4thQqaRTLxP7Dz6Yc5ykIwMe4KVqexzLxz7XnIsBnpVoI3ghqlhI6WNRVjLW2svYy9LxonKyCLconLzLRiM9meTjtihs2WW7dyHJIKkDW2v1aomSlNrYcsr_Qb0Tqy3YkdRthnz0Dyeb2EGmperKY_74XE8FhU79v8vjXxTS5WTJSxHToIiObv4fCrfgRmt4sv2GUm7DFVffgWvHbWj9Lvyg5OSmafc5m3t2SuUgaIiy6bdwkRFrogv0ragrRpmlrGkDzc6ad26M7yUMbWDmvtvZmnQi6-ouZ-eMEkUoLQlP8mJuSzS3YJR8j9OyZE8yNH1nODNCare4B5-ODj--fhO3VzbEFl2TVWxTi_amV7yUZanRl5NVWQyd4lYOS69EVXqvUwrl0kUMlc1sji4qr7yTIvFlmt6H7Xpeu4fAMl7k3iYoAOVQCMm1sl5YJ9BltXkhhxG86E7RnDadOUzwaLQyzUYb3GgTNtqoCA7ooDcjqat2-GO--GJaJjVZKnVeJaEAVyhpUXPznKvMOZWgHhARPCcyMcT7SAu2aEsYcMHURcvso2-G5idiFsFubyTyrO2DO0IzrcxYGq6T0P6NywiebsD0JOXB1W6-pjHDLEcTK8G1PGjocoNSmhHuOUJ0j2J7OPch9fRr6ChOFzZrkacRvOwI92Jdf9_UR_82_DFc54H2Rcz1LmyvFmv3BK7as9V0uRjAVjbJwqcewM7B4Wj8fhDekOCv8dvj8edBYPOfAc9JUQ |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JbxMxFLaqFgEX9iVQwEggDjDtjGN7PAeEylI1ahLlUFB7MjMeGyKFSchSyP_gd_Abec8zkzBFcOuBWxQ7lp_zvc1-CyFPMrARHOd5wIVwAc9yESjlROBEZlmaW5H6LgofunG_r46Pk8EG-VnnwmBYZS0TvaDOxwbvyHeZinxxLCZeTb4G2DUKX1frFholLA7t8hu4bLOXnbfw_z5lbP_d0ZuDoOoqEBhYYB6YtgGTyEmWiSxT4G6IPEtDK5kRYeYkzzPnVBtfG7FXQG5ik4AXxXJnBY9chhegIPK3OIA93CRbg05vcLJ6t4iVkHVqjpK7M5D-WHqXYcwS6MpANtSf7xLwpy74TRmeDdQ881rrleD-1f_t-K6RK5W5TfdK_rhONmxxg1zsVQEFN8kPDMkuS5Uv6djRCSbBgPlNh198-yZavqngp7TIKcbT0rL4NT0tbxop24koWP7UfjejBVoCtM42HS0phsdgMBbgd722QU6bUkw5gGVptCMoGPwjWBlGCju9Rd6fy5ncJpvFuLB3CY1ZmjgTgdgXIeeCKWkcN5aDo26SVIQt8rzGj56U9Ui09-OU1CXaNKBNe7Rp2SKvEWKrmVhL3H8xnn7SlWjScVuoJI982jGXwoC9whImY2tlBNqPt8gzBKhGiQcoNGmVuAEbxtpheg88UjC6gbIW2W7MBEllmsM1NnUlKWd6DcwWebwaxl9i9F9hxwucE8YJGJYR7OVOyRErktox0p7AiGrwSoPm5kgx_OzrqGObasWTdou8qNlqva-_H-q9f5PxiFw6OOp1dbfTP7xPLjPP_DxgaptszqcL-4BcMKfz4Wz6sBIelHw8b4b7BfRQrCE |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3JbtQw1IKCKi7sS6CAkZA4QNrEsR3nWJYRiDKqWKrerNix6UjTzCgzU9H_4IN5z0mmTYED4hbFjuVnvzVvI-S5AR3Bc17FXAgfc1OJWCkvYi-MY2XlRBm6KBzs5eOxOjws9s9l8Ydo994l2eY0YJWmerkzr3xL4kruLICrYklbhrFAIINieZlc4WDJYFDX5y8Haz9CroTsU2X--N1AHIWq_b_z5nPC6WLg5AXvaRBKoxv_D85Ncr1TSOlui0G3yCVX3yabnzqX-x3yE4OW22Lep3Tm6RzTREBBpZPj0OCItl4HfCrrimLEKW3LQ9OT9l8cZdspBd2Yuh92ukJZSft8zOkpxQASDFeCGz5b2yIuNhSD8mFZmm4LCirxFFaGkdo1d8m30buvb97HXSuH2ILJsoxtZkEP9ZIZYYwCG09UpkycZFYkxkteGe9Vhi5ebNBQ2dwWYLqyyjvBU2-y7B7ZqGe1e0BozsrC2xQYo0g4F0xJ67l1HExZW5QiicjL_kb1vK3YoYOlo6RuD1rDQetw0FpG5DVe-nomVtsOL2bNd90Rr84zoYoqDYm5XAoLEp0VTObOyRTkA4_IC0QZjTwB8MKWXWoDbBira-ldsNlALQXIIrI1mAm0bIfDPdLpjpcsNFNpKAvHRESerYfxS4yPq91shXOSvADVK4W93G9xdA1SliPsBYyoAfYOYB6O1JOjUGkcGzkrXmQRedUj8dm-_n6oD_9t-lOyuf92pPc-jD8-ItdYIAMeM7VFNpbNyj0mV-3JcrJongTa_gWpD08J |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reliability+of+prostate+imaging+reporting+and+data+system+version+2.1+for+excluding+clinically+significant+prostate+cancer+using+a+1.5+tesla+scanner&rft.jtitle=BMC+urology&rft.au=Sharqawi%2C+Abdallah&rft.au=Drye%2C+Naomi&rft.au=Shugaba%2C+Abdul&rft.au=O%E2%80%99reilly%2C+Alison&rft.date=2023-04-28&rft.pub=BioMed+Central&rft.eissn=1471-2490&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12894-023-01241-6&rft.externalDocID=10_1186_s12894_023_01241_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2490&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2490&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2490&client=summon |